The therapeutic potential of mTOR inhibitors in breast cancer
- Authors
- Acevedo-Gadea
- Alayev
- Alayev
- Andre
- André
- Arena
- Bachelot
- Baer
- Baselga
- Baselga
- Baselga
- Bendell
- Berns
- Bertrand
- Blackwell
- Bostner
- Bostner
- Bradshaw
- Brohée
- Buckner
- Campone
- Chan
- Chappell
- Chatterjee
- Chi
- Choi
- Ciuffreda
- Dancey
- Davis
- Deluche
- Ding
- Divers
- Fitzgerald
- Fleming
- Follo
- Fragoso
- Gnant
- Gonzalez-Angulo
- Gonzalez-Angulo
- Guichard
- Gupta
- Holder
- Hortobagyi
- Hortobagyi
- Hurvitz
- Jerusalem
- Jerusalem
- Jhanwar-Uniyal
- Ji
- Jiang
- Kabos
- Karthik
- Landis
- Laurent
- Leontieva
- Leung
- Lumachi
- Ma
- Maertens
- Martelli
- Massarweh
- McCubrey
- McCubrey
- McCubrey
- McCubrey
- Mi
- Miller
- Minckwitz
- Minckwitz
- Morrow
- Nagata
- Noguchi
- Novartis Pharmaceuticals
- Piccart
- Piha-Paul
- Qiao
- Royce
- Rugo
- Seller
- Singh
- Southwest Oncology Group
- Spinelli
- Tanaka
- Toker
- Treilleux
- Ukaji
- Untch
- Vaillant
- Wang
- Whittle
- Wolff
- Yamamoto-Ibusuki
- Yardley
- Zucchini
- Publication date
- Publisher
- 'Wiley'
- Doi